Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities
Net loss	$ (1,262)	$ (323)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization expense - intangible asset	40	40
Fair value of vested restricted stock units	76	20
Changes in operating assets and liabilities:
Vendor advances	636
Prepaid expenses and other current assets	(17)	(11)
Accounts payable and accrued expenses	(187)	310
Net cash provided by (used in) operating activities	(714)	36
Cash Flows from Financing Activities
Sale and exercise of prefunded warrants	3,058
Payment of deferred offering costs		(89)
Net cash provided by (used in) financing activities	3,058	(89)
Net increase (decrease) in cash	2,344	(53)
Cash and cash equivalents beginning of period	1,272	93
Cash and cash equivalents end of period	3,616	40
Supplemental cash flows disclosures:
Interest paid
Taxes paid
Supplemental non-cash financing disclosures:
Common shares issued for deferred offering costs	328
Common shares issued for vendor advance	$ 156